Napo Pharmaceuticals published a press release detailing its expanded Mytesi (Crofelemer) Patient Support Program.
To support providers’ patients with access services from reimbursement and prior authorization support to appeals and patient assistance dispensing for Mytesi, Napo is working with Florida-based AssistRx to design and implement a comprehensive patient support services program. AssistRx has extensive experience supporting HIV patients and has developed an industry-leading technology platform called iAssist to streamline therapy initiation.
Read more on Yahoo News—Napo Pharmaceuticals Expands Mytesi (Crofelemer) Patient Support Program
